2026 | Cellworks

Read more about Use of an Integrative Genomics Approach to Identify Metastatic NSCLC Patients Benefiting From the Addition of Chemotherapy to Immune Checkpoint Inhibitors

Read more about Comparison of liquid versus solid tissue genomic profiling for the prediction of chemo-immunotherapy benefit in advanced NSCLC

Read more about Computational modeling of comprehensive genomic profiling to predict chemo-immunotherapy benefit in early stage NSCLC

Read more about An evidence-based tool to systematically identify potential adverse drug-drug interactions.

Subscribe to 2026

Top